Sol-Gel Technologies (SLGL) Property, Plant & Equipment (Net) (2016 - 2026)

Sol-Gel Technologies (SLGL) Property, Plant & Equipment (Net) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,200.25 Bn 66,199.96 Bn - 642,333.36
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.43 Bn 62.43 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 518.26 Mn
10 Sol-Gel Technologies 230.57 Mn 220.43 Mn - 136,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 136,000.00
Mar 31, 2026 136,000.00
Dec 31, 2025 140,000.00
Dec 31, 2025 140,000.00
Sep 30, 2025 145,000.00
Sep 30, 2025 145,000.00
Jun 30, 2025 162,000.00
Jun 30, 2025 162,000.00
Mar 31, 2025 183,000.00
Mar 31, 2025 183,000.00
Dec 31, 2024 202,000.00
Dec 31, 2024 202,000.00
Sep 30, 2024 250,000.00
Sep 30, 2024 250,000.00
Jun 30, 2024 305,000.00
Jun 30, 2024 305,000.00
Mar 31, 2024 366,000.00
Mar 31, 2024 366,000.00
Dec 31, 2023 434,000.00
Dec 31, 2023 434,000.00